GCM
GH icon

Gables Capital Management’s Guardant Health GH Stock Holding History

Gables Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-600
Closed -$16.3K – 378
2022
Q4 		$16.3K Buy
+600
New +$27.5K 0.01% 255

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gables Capital Management's GH Position: Q1 2023 in Review

Gables Capital Management sold out of Guardant Health (GH) in Q1 2023, closing a stake of 600 shares — an estimated $16.3K sold.

Gables Capital Management first reported a position in GH in Q4 2022 and held it in 1 quarter. The position peaked at $16.3K in Q4 2022. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

  • Gables Capital Management reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
  • Gables Capital Management sold 600 Guardant Health shares in Q1 2023, an estimated $16.3K.
  • Gables Capital Management first reported a position in Guardant Health in Q4 2022 and held it in 1 quarter.
  • Gables Capital Management's Guardant Health position peaked at $16.3K in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Gables Capital Management's 13F filing for Q1 2023, filed 4 May 2023.